Cover Image

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson's Disease

Existing therapies for Parkinson's disease (PD) are only symptomatic. As erythropoietin (EPO) is emerging for its benefits in neurodegenerative diseases, here, we test the protective effect driven by EPO in in vitro (SH-SY5Y cells challenged by MPP<sup>+</sup>) and in vivo (C57BL/6J...

Full description

Saved in:

Bibliographic Details
Main Authors:	Federica Rey (Author), Sara Ottolenghi (Author), Toniella Giallongo (Author), Alice Balsari (Author), Carla Martinelli (Author), Robert Rey (Author), Raffaele Allevi (Author), Anna Maria Di Giulio (Author), Gian Vincenzo Zuccotti (Author), Serena Mazzucchelli (Author), Roberta Foresti (Author), Michele Samaja (Author), Stephana Carelli (Author)
Format:	Book
Published:	MDPI AG, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Erythropoietin and Its Analogues as Therapeutics for Neurological Diseases
by: Michael Brines, et al.
Published: (2022)

Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis
by: Marta Sevieri, et al.
Published: (2023)

Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications
by: Cecilia Pandini, et al.
Published: (2023)

Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use
by: Serafina Perrone, et al.
Published: (2022)

Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?
by: Sara Ottolenghi, et al.
Published: (2021)

Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury
by: Titikorn Chunchai, et al.
Published: (2022)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
by: Hendrik S. Fischer, et al.
Published: (2021)

Redox Imbalance in Neurological Disorders in Adults and Children
by: Federica Rey, et al.
Published: (2023)

Neuroprotective Agents for Management of Parkinson's disease
by: Leila Kouti, et al.
Published: (2015)

Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects
by: Oksana Dmytriyeva, et al.
Published: (2016)

Editorial: Neuroprotection and Disease Modification in Parkinson's Disease
by: Matilde Otero-Losada, et al.
Published: (2021)

Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
by: Michelangela Barbieri, et al.
Published: (2024)

Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin
by: Filippo Silva, et al.
Published: (2021)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson's Disease
by: Ikuko Miyazaki, et al.
Published: (2023)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
by: Shinichi Takahashi, et al.
Published: (2022)

Neuroprotective effects of Shende'an tablet in the Parkinson's disease model
by: Xiaoyan Sheng, et al.
Published: (2021)

The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
by: Moon Sun Kim, et al.
Published: (2010)

Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis
by: Ji Eun Jeong, et al.
Published: (2017)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease
by: Xinyu Hu, et al.
Published: (2023)

Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II
by: Matilde Otero-Losada, et al.
Published: (2023)

Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease
by: Dingyi Yu, et al.
Published: (2021)

Correction: Neuroprotective effects of Shende'an tablet in the Parkinson's disease model
by: Xiaoyan Sheng, et al.
Published: (2024)

Gene therapy: a promising approach for neuroprotection in Parkinson's disease?
by: Pamela Valdés, et al.
Published: (2016)

Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities
by: Federica Rey, et al.
Published: (2019)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
by: Ojha S, et al.
Published: (2015)

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
by: Juan Segura-Aguilar
Published: (2017)

Addressing the Neuroprotective Actions of Coffee in Parkinson's Disease: An Emerging Nutrigenomic Analysis
by: Lai Kuan Lee, et al.
Published: (2022)

Intranasal mucoadhesivemicroemulsion for neuroprotective effect of curcuminin mptp induced Parkinson model
by: Snigdha Das Mandal, et al.
Published: (2017)

Natural Nanoparticles: A Safe Bullet for Treatment and Detection of Solid Tumors
by: Serena Mazzucchelli
Published: (2022)

Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson's disease model
by: Noor Azzizah Omar, et al.
Published: (2023)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
by: Keserla Bhavani, et al.
Published: (2023)

Impact of neuroprotective therapy on cognition and oxidative stress in the early stages of Parkinson's disease
by: A. V. Demchenko, et al.
Published: (2021)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo
by: Tian Wang, et al.
Published: (2020)

Pleiotropic effects of Erythropoietin. Influence of Erythropoietin on processes of mesenchymal stem cells differentiation
by: Ekaterina V. Zubareva, et al.
Published: (2019)

ERYTHROPOIETIN AS DOPING AGENT
by: Nina Đukanović, et al.
Published: (2012)

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
by: Arianna Bonizzi, et al.
Published: (2019)

Respiratory infections and immunostimulants in childhood: an update
by: Gian Vincenzo Zuccotti, et al.
Published: (2015)

Antipneumococcal vaccination
by: Gian Vincenzo Zuccotti, et al.
Published: (2013)

Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models
by: Giuseppe Carota, et al.
Published: (2022)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease Models
by: Andrée-Anne Poirier, et al.
Published: (2022)